FdaApplication
BLA 125335
Identifiers
- fda_app_no: BLA125335
Properties
| Property | Value |
|---|---|
| applicant_name | Rare Disease Therapeutics, Inc. (RDT) |
| application_type | BLA |
| approval_date | 2011-08-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANASCORP | — | >/=150 LD50 NEUTRALIZING UNITS | For Injection |
1 product